Latest Breaking News On - Panel discussiontitle - Page 1 : vimarsana.com

MELBOURNE, Australia and PRINCETON, N.J., May 01, 2024 (GLOBE NEWSWIRE) Opthea Limited (NASDAQ:OPT, the "Company")), a clinical-stage biopharmaceutical company developing novel therapies to treat highly prevalent

United statesFort lauderdaleSilvana guerci lenaJordanag feinDavid eichenbaumFrederic guerardExchange commissionOpthea limitedRetina world congressLifesci advisorsPanel discussiontitleRetina group of washingtonResearch at retina vitreous associates of floridaChief executive officerRetina unpluggedSession title